Kattan et al developed a nomogram for predicting biochemical progression at 5 years in clinically localized prostate cancer based on preoperative variables. This can help identify patients who may benefit from more aggressive therapy and monitoring. The authors are from Baylor College of Medicine and Memorial Sloan-Kettering Cancer Center.
Patient selection: localized prostate cancer (clinical T1c, T2 or T3a)
Parameters:
(1) preoperative PSA in ng/mL
(2) primary Gleason grade on the prostate biopsy
(3) secondary Gleason grade on the prostate biopsy
(4) clinical stage
(5) preoperative interleukin-6 soluble receptor (IL6 SR) in ng/mL
(6) preoperative transforming growth factor beta1 (TGF beta1) in ng/mL
Primary Gleason Grade |
Points |
2 |
0 |
3 |
1 |
1 |
2 |
4 |
18 |
5 |
38 |
Secondary Gleason Grade |
Points |
1 |
0 |
2 |
1 |
3 |
3 |
4 |
13 |
5 |
24 |
Clinical Stage |
Points |
T2a |
0 |
T2c |
1 |
T3a |
2 |
T1c |
4 |
T2b |
8 |
Serum PSA in ng/mL |
Points |
0.2 |
0 |
15 |
9 |
25 |
16 |
50 |
26 |
100 |
37 |
This data can be approximated in JMP as:
points for PSA =
= (-0.00319 * ((PSA)^2)) + (0.6896556 * (PSA)) - 0.115984
IL6 SR in ng/mL |
Points |
5 |
0 |
10 |
8 |
15 |
17 |
20 |
26 |
25 |
35 |
30 |
43 |
35 |
51 |
40 |
60 |
45 |
68 |
50 |
77 |
This data can be approximated in JMP as:
points for IL6 SR =
= (1.710303 * (IL6 SR)) - 8.5333
TGF beta1 in ng/mL |
Points |
0.5 |
0 |
1 |
19 |
2 |
38 |
3 |
50 |
4 |
58 |
5 |
65 |
6 |
70 |
7 |
74 |
8 |
78 |
9 |
81 |
10 |
84 |
11 |
86 |
12 |
90 |
13 |
92 |
14 |
94 |
17 |
99 |
This data can be approximated in JMP as:
points for TGF beta1 from 0.5 to 4.0 =
= ((1.5382514 * ((TGF)^3)) - (14.61633 * ((TGF)^2)) + (54.1777 * (TGF)) - 23.14786
points for TGF beta1 from 4.0 to 17 =
= ((0.0101831 * ((TGF)^3)) - (0.481817 * ((TGF)^2)) + (9.4378323 * (TGF)) + 27.9853
total score =
= SUM(points for all 6 parameters)
Score |
Probability of Being Biochemical Progression Free at 60 Months |
< 61 |
> 99% |
61 - 123 |
((-0.000064 * ((points)^3)) + (0.011702 * ((points)^2)) - (0.771897 * (points)) + 117.0784) / 100 |
123 - 183 |
((0.0005283 * ((points)^3)) - (0.2368 * ((points)^2)) + (33.567766 * (points)) - 1449.617) / 100 |
> 183 |
< 1% |
Specialty: Hematology Oncology, Surgery, general, Urology